Breaking News Instant updates and real-time market news.

TEVA

Teva

$30.55

0.33 (1.09%)

15:18
06/12/17
06/12
15:18
06/12/17
15:18

Teva announces launch of generic Zetia in U.S.

Teva Pharmaceutical Industries announced the launch of generic Zetia tablets, 10 mg, in the U.S. Ezetimibe is a prescription medicine used to lower levels of total cholesterol and low-density lipoprotein cholesterol in the blood. Ezetimibe tablets are for patients who cannot control their cholesterol levels by diet and exercise alone. It can be used by itself or with other medicines to treat high cholesterol. Ezetimibe tablets work to reduce the amount of cholesterol the body absorbs. "Despite advances in the treatment of high cholesterol in recent years, many people are still living with active disease and are in need of additional generic therapeutic options," said Dipankar Bhattacharjee, Teva's President and CEO, Global Generic Medicines. "We are excited to add another strong generic to our U.S. portfolio and see potential to build on its success by leveraging our expertise in the cardiovascular area."

  • 22

    Jun

  • 30

    Aug

TEVA Teva
$30.55

0.33 (1.09%)

05/11/17
WELS
05/11/17
NO CHANGE
WELS
Market Perform
Teva faces 'underappreciated risk' from major generic RFPs, says Wells Fargo
Wells Fargo analyst David Maris noted that Teva's generic drug price erosion came in at 7% in Q1, adding that Teva's management, which previously indicated that they expected price erosion in the U.S. to be 5%, "did not explain well" how the factors that negatively impacted prices were not fully anticipated. Also, there are currently two major generic Request for Proposals out for bid - one from Express Scripts (ESRX), Albertson's and Kroger (KR) and one from Walmart (WMT) and McKesson (MCK) - and the potential price reset from these is an "underappreciated risk" facing Teva, added Maris, who keeps a Market Perform rating on the stock.
05/02/17
LEHM
05/02/17
NO CHANGE
Target $70
LEHM
Overweight
Neurocrine price target raised to $70 from $60 at Barclays
Barclays analyst Geoff Meacham raised his price target for Neurocrine Biosciences (NBIX) to $70 and maintains an Overweight rating on the shares. Ingrezza pricing came in ahead of expectations at $50,000 per year net, Meacham tells investors in a research note. He believes the net cost of Ingrezza is favorably positioned relative to Teva's (TEVA) Austedo.
05/01/17
JEFF
05/01/17
NO CHANGE
Target $67
JEFF
Buy
Jefferies ups Neurocrine target on 'encouraging' doctor survey
Jefferies analyst Biren Amin raised his price target for Neurocrine Biosciences (NBIX) to $67 from $65 after his firm, for the second time, surveyed 50 U.S. doctors on the current and future Tardive Dyskinesia treatment landscape. The shares closed Friday down 19c to $53.40. The respondents estimate "significant uptake" of both Neurocrine's valbenazine and Teva's (TEVA) Austedo with a "clear preference" for valbenazine, Amin tells investors in a research note. The analyst now expects valbenazine to capture a larger share than Austedo in moderate-to-severe Tardive Dyskinesia. Amin keeps a Buy rating on Neurocrine shares.
04/25/17
WELS
04/25/17
NO CHANGE
WELS
Novartis results highlight tough pricing environment, says Wells Fargo
This morning's Q1 results from Novartis' (NVS) Sandoz division highlight the difficult U.S. generic price environment, Wells Fargo analyst David Maris tells investors in a research note. Sandoz experienced pricing erosion of 8% in the quarter, which represents the largest negative impact from pricing in recent quarters, Maris writes. He expects the negative U.S. pricing environment to impact including Mallinckrodt (MNK), Teva (TEVA), Mylan (MYL) and Perrigo (PRGO). Maris remains cautious on the pricing environment for generics.

TODAY'S FREE FLY STORIES

FL

Foot Locker

$39.80

7.95 (24.96%)

12:32
11/17/17
11/17
12:32
11/17/17
12:32
Upgrade
Foot Locker rating change  »

Deutsche sees sustained…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

XRT

S&P Retail Index SPDR

$41.59

0.98 (2.41%)

12:30
11/17/17
11/17
12:30
11/17/17
12:30
Options
Defensive short-term play in SPDR Retail ETF »

Defensive short-term play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
11/17/17
11/17
12:30
11/17/17
12:30
General news
Breaking General news story  »

San Francisco Federal…

FTI

TechnipFMC

$26.72

0.175 (0.66%)

12:25
11/17/17
11/17
12:25
11/17/17
12:25
Options
FMC Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

$NSD

NASDAQ Market Internals

12:17
11/17/17
11/17
12:17
11/17/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$11.25

0.18 (1.63%)

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Options
AMD calls outpace puts 4:1 as shares advance »

AMD calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

TSLA

Tesla

$312.50

1.2 (0.39%)

, AMZN

Amazon.com

$1,137.29

10.6 (0.94%)

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Hot Stocks
Tesla, Amazon look to shake up trucking industry with new vehicle, app »

Shares of third-party…

TSLA

Tesla

$312.50

1.2 (0.39%)

AMZN

Amazon.com

$1,137.29

10.6 (0.94%)

CHRW

C.H. Robinson

$80.40

0.45 (0.56%)

LSTR

Landstar System

$96.80

1.75 (1.84%)

XPO

XPO Logistics

$74.29

0.1035 (0.14%)

JBHT

J.B. Hunt

$102.98

1.44 (1.42%)

WMT

Wal-Mart

$96.94

-2.68 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 28

    Nov

  • 07

    Dec

  • 11

    Dec

  • 09

    Jan

  • 16

    Jan

  • 20

    Feb

  • 18

    Mar

$NYE

NYSE Market Internals

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$11.36

-0.58 (-4.86%)

12:12
11/17/17
11/17
12:12
11/17/17
12:12
Recommendations
MiMedx analyst commentary  »

MiMedx growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 01

    Dec

XOP

SPDR Oil Exploration and Production Fund

$34.83

0.525 (1.53%)

12:00
11/17/17
11/17
12:00
11/17/17
12:00
Options
Defensive short-term option play in SPDR Oil Exploration and Production ETF »

Defensive short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNK

Teekay Tankers

$1.41

0.01 (0.71%)

11:55
11/17/17
11/17
11:55
11/17/17
11:55
Conference/Events
Teekay Tankers to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

TWX

Time Warner

$88.53

0.52 (0.59%)

, VIA

Viacom

$30.10

-0.65 (-2.11%)

11:50
11/17/17
11/17
11:50
11/17/17
11:50
Hot Stocks
Box Office Battle: 'Justice League' to vanquish 'Thor' in debut »

The major release opening…

TWX

Time Warner

$88.53

0.52 (0.59%)

VIA

Viacom

$30.10

-0.65 (-2.11%)

VIAB

Viacom

$23.69

-0.92 (-3.74%)

LGF.A

Lionsgate

$32.32

1.28 (4.12%)

LGF.B

Lionsgate

$30.70

1.17 (3.96%)

DIS

Disney

$103.61

0.01 (0.01%)

FOX

21st Century Fox

$28.60

0.65 (2.33%)

FOXA

21st Century Fox

$29.32

0.59 (2.05%)

CMCSA

Comcast

$37.07

-0.11 (-0.30%)

CMCSK

Comcast

SNE

Sony

$46.20

0.1 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANF

Abercrombie & Fitch

$15.49

2.9398 (23.42%)

11:50
11/17/17
11/17
11:50
11/17/17
11:50
Recommendations
Abercrombie & Fitch analyst commentary  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

HFWA

Heritage Financial

$30.60

0.3 (0.99%)

11:48
11/17/17
11/17
11:48
11/17/17
11:48
Hot Stocks
Heritage Financial, Puget Sound Bancorp deal receives regulatory approvals »

Heritage Financial, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$46.81

0.215 (0.46%)

11:40
11/17/17
11/17
11:40
11/17/17
11:40
Options
108K iShares Emerging Markets Fund Dec 44.5 puts bought for 22c »

108K iShares Emerging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
11/17/17
11/17
11:35
11/17/17
11:35
General news
Euro$ interest rate futures recovered from lows »

Euro$ interest rate…

ANF

Abercrombie & Fitch

$16.00

3.45 (27.49%)

11:31
11/17/17
11/17
11:31
11/17/17
11:31
Downgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

M

Macy's

$20.63

0.38 (1.88%)

11:30
11/17/17
11/17
11:30
11/17/17
11:30
Options
Calendar risk reversal in Macys may roll call gains into put protection »

Calendar risk reversal in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ANF

Abercrombie & Fitch

$15.94

3.39 (27.01%)

11:28
11/17/17
11/17
11:28
11/17/17
11:28
Downgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

AAPL

Apple

$171.10

2.02 (1.19%)

11:24
11/17/17
11/17
11:24
11/17/17
11:24
Periodicals
Apple delays release of HomePod to early 2018, TechCrunch reports »

Apple is delaying the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$110.15

-0.87 (-0.78%)

, MA

MasterCard

$148.53

-1.7995 (-1.20%)

11:23
11/17/17
11/17
11:23
11/17/17
11:23
Recommendations
Visa, MasterCard analyst commentary  »

Visa highlights possible…

V

Visa

$110.15

-0.87 (-0.78%)

MA

MasterCard

$148.53

-1.7995 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 29

    Nov

GLD

SPDR Gold Trust

$122.32

0.92 (0.76%)

11:20
11/17/17
11/17
11:20
11/17/17
11:20
Options
Far downside put buyers in SPDR Gold ETF as the metal trades higher »

Far downside put buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
11/17/17
11/17
11:17
11/17/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
11/17/17
11/17
11:16
11/17/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$312.50

1.2 (0.39%)

, WMT

Wal-Mart

$97.67

-1.952 (-1.96%)

11:05
11/17/17
11/17
11:05
11/17/17
11:05
Periodicals
Wal-Mart to test new Tesla electric trucks, CNBC reports »

Following Tesla's…

TSLA

Tesla

$312.50

1.2 (0.39%)

WMT

Wal-Mart

$97.67

-1.952 (-1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 16

    Jan

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.